Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. - Åkerblom A; Wojdyla D; Steg PG; Wallentin L; James SK; Budaj A; Katus HA; Himmelmann A; Huber K; Siegbahn A; Storey RF; Becker RC (Journal of thrombosis and thrombolysis, 2019)